DrKC leads new investors in Inpharmatica

The drug discovery company has raised £31.25m in a second round private placement managed by CSFB.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this